does medicaid cover glp 1 medications Did you know? Approximately 36% of Ohioans are dealing with obesity. Addressing this challenge requires modern, science-based solutions. GLP-1 are helping patients reduce weight, lower their risk of chronic disease, and Does Medicaid Cover GLP-1 Drugs?

"We're very much committed to trying to pull that [timeline] in as much as possible," he added

The judge overseeing the group lawsuit will hold a hearing on May 14, 2025, to discuss this issue

Cardiovasc Diabetol 21:169

CV outcomes for adult patients with type 2 diabetes and established cardiovascular disease LEADERa landmark CVOT for Victoza 1 9,340 patients Key inclusion criteria: T2D, A1C 7.0% Age 50 years and established CVD OR Age 60 years and risk factors for CVD Cardiovascular standards of care (antihypertensives, lipid-lowering agents, and antiplatelet therapy) Diabetes standards of care (lifestyle modification, OADs, and insulin) Duration 3.5-5 years Time to first major adverse cardiovascular event (MACE) composed of: Composite primary endpoint CV death Nonfatal MI Nonfatal stroke Prospectively designed and powered to assess noninferiority and then superiority Patients were titrated to maximum tolerated dose of 0.6 mg to 1.8 mg Median daily dose of Victoza was 1.78 mg Victoza significantly reduced MACE in adults with T2D and established CVD 1 Absolute risk reduction: 1.9% Median time of exposure to treatment: 3.5 years

Many commercial plans exclude weight loss medications entirely or cover them only for patients with BMI 30 kg/m or BMI 27 kg/m with weight-related comorbidities